Conclusion
The incidence of SCEs remains at 23.1% in patients on uninterrupted OAC
for AF ablation. LAD, baseline ACT, and time to reach optimal ACT are
significant risk factors for SCE. Intra-procedural ACT kinetics vary
among anticoagulants, which should be considered when estimating the
risk of SCEs.